0001209191-19-014100.txt : 20190227
0001209191-19-014100.hdr.sgml : 20190227
20190227165724
ACCESSION NUMBER: 0001209191-19-014100
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190225
FILED AS OF DATE: 20190227
DATE AS OF CHANGE: 20190227
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WENTWORTH KORY JAMES
CENTRAL INDEX KEY: 0001725663
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35966
FILM NUMBER: 19638540
MAIL ADDRESS:
STREET 1: 60 BINNEY STREET
STREET 2: C/O BLUEBIRD BIO, INC.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: bluebird bio, Inc.
CENTRAL INDEX KEY: 0001293971
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 60 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 339-499-9300
MAIL ADDRESS:
STREET 1: 60 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Genetix Pharmaceuticals Inc
DATE OF NAME CHANGE: 20040616
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-02-25
0
0001293971
bluebird bio, Inc.
BLUE
0001725663
WENTWORTH KORY JAMES
C/O BLUEBIRD BIO, INC.
60 BINNEY STREET
CAMBRIDGE
MA
02142
0
1
0
0
Principal Accounting Officer
Common Stock
2019-02-25
4
S
0
208
150.0038
D
6746
D
The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on December 19, 2018.
The range in prices for the transaction reported on this line was $150.00 to $150.10. The average weighted price was $150.0038. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
/s/ Jason F. Cole, Attorney-in-Fact
2019-02-27